Mags Houston's guest appearances

Mags Houston

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

OwlTail

Hannah Deacon

Matt Hughes

In this week’s episode, we’re joined by Mags Houston from Drug Science, Mary Biles (author of The CBD Book), Matt Hughes from MedCan Support, and Hannah Deacon from The Medical Cannabis Clinicians Society to discuss the upcoming UK Patient Conference on 4th Nov in London. We discuss the importance of patient conferences to patients themselves, parents, and anyone interested in learning more about cannabis-based medicines.The upcoming conference will feature talks from some of the leading experts in the field, as well as opportunities to learn about patient experiences, the latest research, and developments. Whether you're new to the topic or have been following the medical cannabis debate for some time, this is a great opportunity to get involved and learn more. This promises to be a fascinating and informative event, so if you are a patient or interested in medical cannabis then make sure you register for free today for the livestream - unfortunately in-person tickets are all sold out!Date and time: Fri, 4 Nov 2022, 10:30 – 18:30 GMTTickets are available through this link: UK Patience ConferenceThe Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at www.luminorecruit.com/About Our GuestsMags HoustonAs Head of Projects &amp; Comms for Drug Science, Mags oversees the running of Drug Science’s medical cannabis observational study, Project Twenty21. The study helps to raise awareness of medical cannabis, building more evidence by attracting more patients and prescribers to actively join the project, and educating the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Matt HughesHaving campaigned for NHS access to prescription his son Charlie since 2019 and the knowledge he gained through experience, In collaboration with Hannah Deacon, Matt formed MedCan Support, having felt there was a gap in education for parents, carers and families. Building a central forum to educate and inform parents and carers so they can work with their doctors to make informed decisions on their loved ones care. To provide a safe space for parents and carers to ask questions about prescription cannabis and feel confident to advocate for their child or family members health care needs.Hannah DeaconMedical cannabis expert &amp; campaigner Hannah Deacon is one of the most influential and high-profile female leaders in the UK's medical cannabis sector.With an international reputation for pioneering change, as a dedicated patient advocate, Hannah also works to overcome barriers to medical cannabis treatment in the UK, supporting better education for doctors so patients across the country get the access they need.Mary BilesMary Biles is the author of The CBD Book, a regular contributor to Project CBD and host of the podcast Cannabis Voices. She is a vocal advocate of greater access to medicinal cannabis for patients and fostering an industry where patients' needs are firmly held at the centre of companies' business models.

In this week’s episode, we’re joined by Mags Houston from Drug Science, Mary Biles (author of The CBD Book), Matt Hughes from MedCan Support, and Hannah Deacon from The Medical Cannabis Clinicians Society to discuss the upcoming UK Patient Conference on 4th Nov in London. We discuss the importance of patient conferences to patients themselves, parents, and anyone interested in learning more about cannabis-based medicines. The upcoming conference will feature talks from some of the leading experts in the field, as well as opportunities to learn about patient experiences, the latest research, and developments. Whether you're new to the topic or have been following the medical cannabis debate for some time, this is a great opportunity to get involved and learn more. This promises to be a fascinating and informative event, so if you are a patient or interested in medical cannabis then make sure you register for free today for the livestream - unfortunately in-person tickets are all sold out!Date and time: Fri, 4 Nov 2022, 10:30 – 18:30 GMTTickets are available through this link: <a href="https://www.eventbrite.co.uk/e/uk-patient-conference-medical-cannabis-awareness-week-2022-tickets-335415074517?aff=ebdssbdestsearch" rel="nofollow" target="_blank">UK Patience Conference</a> The Cannabis Conversation is sponsored by <a href="https://luminorecruit.com/?utm_source=TCC&amp;utm_medium=podcast" rel="nofollow" target="_blank">Lumino</a> - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at<a href="https://luminorecruit.com/?utm_source=TCC&amp;utm_medium=podcast" rel="nofollow" target="_blank"> www.luminorecruit.com/</a> About Our GuestsMags HoustonAs Head of Projects &amp; Comms for <a href="https://www.drugscience.org.uk/" rel="nofollow" target="_blank">Drug Science</a>, Mags oversees the running of Drug Science’s medical cannabis observational study, Project Twenty21. The study helps to raise awareness of medical cannabis, building more evidence by attracting more patients and prescribers to actively join the project, and educating the public about the growing evidence surrounding medical cannabis for treating a range of conditions.  Matt HughesHaving campaigned for NHS access to prescription his son Charlie since 2019 and the knowledge he gained through experience, In collaboration with Hannah Deacon, Matt formed MedCan Support, having felt there was a gap in education for parents, carers and families. Building a central forum to educate and inform parents and carers so they can work with their doctors to make informed decisions on their loved ones care. To provide a safe space for parents and carers to ask questions about prescription cannabis and feel confident to advocate for their child or family members health care needs. Hannah Deacon Medical cannabis expert &amp; campaigner Hannah Deacon is one of the most influential and high-profile female leaders in the UK's medical cannabis sector.With an international reputation for pioneering change, as a dedicated patient advocate, Hannah also works to overcome barriers to medical cannabis treatment in the UK, supporting better education for doctors so patients across the country get the access they need. Mary BilesMary Biles is the author of The CBD Book, a regular contributor to Project CBD and host of the podcast <a href="https://www.marybiles.com/podcast" rel="nofollow" target="_blank">Cannabis Voices</a>. She is a vocal advocate of greater access to medicinal cannabis for patients and fostering an industry where patients' needs are firmly held at the centre of companies' business models.

EPISODE #172: Medical Cannabis Patients with Mags Houston, Matt Hughes, Hannah Deacon, & Mary Biles

Anne Katrin Schlag

This week we’re excited to welcome Mags Houston and Dr. Anne Katrin Schlag from Drug Science - independent science led drugs charity based in London.Together, we explore how ProjectTwenty21 is progressing, some of the initial findings from the participating patient set, alongside digging into the true value of real-world data as a form of medical evidence opposed to randomised controlled trials.The Cannabis Conversation is sponsored by Lumino  - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at www.luminorecruit.com/📚 VIEW SHOW NOTES AND EXTRAS:https://www.canverse.global/shownotes/e149About Dr Anne Katrin Schlag - Head of Research at Drug Science Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science (https://drugscience.org.uk). She leads the research for the Drug Science Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.She holds Honorary Fellowships at both Imperial College London and King’s College London, chairs the research subgroup of the Cannabis Industry Council, and is scientific advisor to the Primary Care Cannabis Network.  About Mags Houston - Head of T21 at Drug ScienceAs Head of Project Twenty21, Mags is the operational lead for Drug Science’s medical cannabis observational study, helping to raise awareness amongst patients and prescribers, build more evidence by attracting more patients and prescribers to actively join the project, and educate the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Alongside her role on T21, she volunteers for Heroic Hearts Project UK, a not-for-profit that helps veterans suffering with PTSD by providing retreats and education in psychedelic therapy. She also curates and hosts events for The Psychedelic Society (UK) around drug policy, psychedelic science and mental health treatment. Mags’ mission is to shift the mainstream narrative around drugs by helping to provide education and challenging UK drug policy, so that therapies and medicines that are currently not accessible to patients might be made available on the NHS and prescribed to the people who desperately need them.ResourcesDrug Science’s Website:  https://www.drugscience.org.ukProject Twenty21: https://www.drugscience.org.uk/project-twenty-21/Join Anne on LinkedIn: https://www.linkedin.com/in/anne-katrin-schlag-3886a4/Join Mags on LinkedIn: https://www.linkedin.com/in/ACoAAAOCG4IBadL6I3LJNez4_WtaJaWoemfjZlQ/

This week we’re excited to welcome Mags Houston and Dr. Anne Katrin Schlag from Drug Science - independent science led drugs charity based in London.Together, we explore how ProjectTwenty21 is progressing, some of the initial findings from the participating patient set, alongside digging into the true value of real-world data as a form of medical evidence opposed to randomised controlled trials.The Cannabis Conversation is sponsored by <a href="https://luminorecruit.com/?utm_source=TCC&amp;utm_medium=podcast" rel="nofollow" target="_blank">Lumino</a>  - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at<a href="https://luminorecruit.com/?utm_source=TCC&amp;utm_medium=podcast" rel="nofollow" target="_blank"> www.luminorecruit.com/</a> 📚 VIEW SHOW NOTES AND EXTRAS:<a href="https://www.canverse.global/shownotes/e145" rel="nofollow" target="_blank">https://www.canverse.global/shownotes/e149</a> About Dr Anne Katrin Schlag - Head of Research at Drug Science Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science (<a href="https://drugscience.org.uk" rel="nofollow" target="_blank">https://drugscience.org.uk</a>). She leads the research for the Drug Science Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.She holds Honorary Fellowships at both Imperial College London and King’s College London, chairs the research subgroup of the Cannabis Industry Council, and is scientific advisor to the Primary Care Cannabis Network.  About Mags Houston - Head of T21 at Drug ScienceAs Head of Project Twenty21, Mags is the operational lead for Drug Science’s medical cannabis observational study, helping to raise awareness amongst patients and prescribers, build more evidence by attracting more patients and prescribers to actively join the project, and educate the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Alongside her role on T21, she volunteers for Heroic Hearts Project UK, a not-for-profit that helps veterans suffering with PTSD by providing retreats and education in psychedelic therapy. She also curates and hosts events for The Psychedelic Society (UK) around drug policy, psychedelic science and mental health treatment. Mags’ mission is to shift the mainstream narrative around drugs by helping to provide education and challenging UK drug policy, so that therapies and medicines that are currently not accessible to patients might be made available on the NHS and prescribed to the people who desperately need them. ResourcesDrug Science’s Website:  <a href="https://www.drugscience.org.uk" rel="nofollow" target="_blank">https://www.drugscience.org.uk</a>Project Twenty21: <a href="https://www.drugscience.org.uk/project-twenty-21/" rel="nofollow" target="_blank">https://www.drugscience.org.uk/project-twenty-21/</a>Join Anne on LinkedIn: <a href="https://www.linkedin.com/in/anne-katrin-schlag-3886a4/" rel="nofollow" target="_blank">https://www.linkedin.com/in/anne-katrin-schlag-3886a4/</a>Join Mags on LinkedIn: <a href="https://www.linkedin.com/in/ACoAAAOCG4IBadL6I3LJNez4_WtaJaWoemfjZlQ/" rel="nofollow" target="_blank">https://www.linkedin.com/in/ACoAAAOCG4IBadL6I3LJNez4_WtaJaWoemfjZlQ/</a>